Recurrent Type III Kounis Syndrome: Will Anti-Immunoglobulin E Drug Be Another Option?
Can J Cardiol
; 36(6): 966.e5-966.e6, 2020 06.
Article
em En
| MEDLINE
| ID: mdl-32536377
Kounis syndrome was recognized as the concurrence of acute cardiovascular events with hypersensitivity reactions. We report a case of Kounis syndrome type III (coronary thrombosis) variant in a 48-year-old man who had experienced recurrent acute myocardial infarctions after scallion-induced hypersensitivity reactions. After appropriate antithrombotic, antihistamine, and reperfusion strategies, the patient was found to have elevated levels of immunoglobulin E and chronic urticaria. Upon administration of omalizumab, there was an improvement of chronic urticaria, a decrease in immunoglobulin E levels, and resolution of the ischemic attacks.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Trombose Coronária
/
Imunoglobulina E
/
Omalizumab
/
Hipersensibilidade Alimentar
/
Síndrome de Kounis
/
Urticária Crônica
Tipo de estudo:
Diagnostic_studies
/
Etiology_studies
Idioma:
En
Revista:
Can J Cardiol
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
China